Tremella fuciformis enhances the neurite outgrowth of PC12 cells and restores trimethyltin-induced impairment of memory in rats via activation of CREB transcription and cholinergic systems

Behavioural Brain Research

Volumn 229, Issue 1, 2012, Pages 82-90

  Park, Hyun Jung ^a,b   Shim, Hyun Soo ^b   Ahn, Yong Ho ^b   Kim, Kyung Soo ^a   Park, Kum Ju ^c   Choi, Woong Ki ^c   Ha, Hyo Cheol ^c   Kang, Jung Il ^c   Kim, Tae Seok ^c   Yeo, Ik Hyun ^c   Kim, Jin Su ^d   Shim, Insop ^b  

^a The Catholic University of Korea   (South Korea)

^b Kyung Hee University   (South Korea)

^c Research Institute of Food and Culture   (South Korea)

^d University of Science and Technology (UST)   (South Korea)

Author keywords

Choline acetyltransferase (ChAT); PC12; Position emission tomography (PET); Tremella fuciformis (TF); Trimethyltin (TMT)

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLUORODEOXYGLUCOSE F 18; FUNGAL EXTRACT; GLUCOSE; NEUROPROTECTIVE AGENT; TREMELLA FUCIFORMIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL STRAIN; CELLULAR DISTRIBUTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LOCALIZATION; FRONTAL LOBE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NERVE FIBER GROWTH; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TREMELLA FUCIFORMIS; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGENTS; CREB-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; NEURITES; NEUROPROTECTIVE AGENTS; PC12 CELLS; POLYSACCHARIDES; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRIMETHYLTIN COMPOUNDS;

EID: 84862781215     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.017     Document Type: Article

References (62)

1. Cannon R.L., Hoover D.B., Baisden R.H., Woodruff M.L. Effects of trimethyltin (TMT) on choline acetyltransferase activity in the rat hippocampus. Influence of dose and time following exposure. Molecular and Chemical Neuropathology/Sponsored by the International Society for Neurochemistry and the World Federation of Neurology and Research Groups on Neurochemistry and Cerebrospinal Fluid 1994, 23:27-45.
2. Cannon R.L., Hoover D.B., Baisden R.H., Woodruff M.L. The effect of time following exposure to trimethyltin (TMT) on cholinergic muscarinic receptor binding in rat hippocampus. Molecular and Chemical Neuropathology/Sponsored by the International Society for Neurochemistry and the World Federation of Neurology and Research Groups on Neurochemistry and Cerebrospinal Fluid 1994, 23:47-62.
3. O'Connell A., Earley B., Leonard B.E. The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat. Neurochemistry International 1994, 25:555-566.
4. O'Connell A., Earley B., Leonard B.E. Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochemistry International 1994, 25:243-252.
5. O'Connell A.W., Earley B., Leonard B.E. The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat. Pharmacology & Toxicology 1996, 78:296-302.
6. Brabeck C., Michetti F., Geloso M.C., Corvino V., Goezalan F., Meyermann R., et al. Expression of EMAP-II by activated monocytes/microglial cells in different regions of the rat hippocampus after trimethyltin-induced brain damage. Experimental Neurology 2002, 177:341-346.
7. Balaban C.D., O'Callaghan J.P., Billingsley M.L. Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 1988, 26:337-361.
8. Geloso M.C., Corvino V., Cavallo V., Toesca A., Guadagni E., Passalacqua R., et al. Expression of astrocytic nestin in the rat hippocampus during trimethyltin-induced neurodegeneration. Neuroscience Letters 2004, 357:103-106.
9. Geloso M.C., Vercelli A., Corvino V., Repici M., Boca M., Haglid K., et al. Cyclooxygenase-2 and caspase 3 expression in trimethyltin-induced apoptosis in the mouse hippocampus. Experimental Neurology 2002, 175:152-160.
10. Ishida N., Akaike M., Tsutsumi S., Kanai H., Masui A., Sadamatsu M., et al. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience 1997, 81:1183-1191.
11. Koczyk D. How does trimethyltin affect the brain: facts and hypotheses. Acta Neurobiologiae Experimentalis 1996, 56:587-596.
12. Dyer R.S. Physiological methods for assessment of Trimethyltin exposure. Neurobehavioral Toxicology and Teratology 1982, 4:659-664.
13. Chang L.W., Dyer R.S. Trimethyltin induced pathology in sensory neurons. Neurobehavioral Toxicology and Teratology 1983, 5:673-696.
14. Chang L.W., Dyer R.S. A time-course study of trimethyltin induced neuropathology in rats. Neurobehavioral Toxicology and Teratology 1983, 5:443-459.
15. Chang L.W., Dyer R.S. Septotemporal gradients of trimethyltin-induced hippocampal lesions. Neurobehavioral Toxicology and Teratology 1985, 7:43-49.
16. Chang L.W., Tiemeyer T.M., Wenger G.R., McMillan D.E. Neuropathology of trimethyltin intoxication. III. Changes in the brain stem neurons. Environmental Research 1983, 30:399-411.
17. Chang L.W., Wenger G.R., McMillan D.E., Dyer R.S. Species and strain comparison of acute neurotoxic effects of trimethyltin in mice and rats. Neurobehavioral Toxicology and Teratology 1983, 5:337-350.
18. Alessandri B., FitzGerald R.E., Schaeppi U., Krinke G.J., Classen W. The use of an unbaited tunnel maze in neurotoxicology. I. Trimethyltin-induced brain lesions. Neurotoxicology 1994, 15:349-357.
19. Cannon R.L., Hoover D.B., Woodruff M.L. Trimethyltin increases choline acetyltransferase in rat hippocampus. Neurotoxicology and Teratology 1991, 13:241-244.
20. Cohen C.A., Messing R.B., Sparber S.B. Selective learning impairment of delayed reinforcement autoshaped behavior caused by low doses of trimethyltin. Psychopharmacology 1987, 93:301-307.
21. Earley B., Burke M., Leonard B.E. Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochemistry International 1992, 21:351-366.
22. Hagan J.J., Jansen J.H., Broekkamp C.L. Selective behavioural impairment after acute intoxication with trimethyltin (TMT) in rats. Neurotoxicology 1988, 9:53-74.
23. Messing R.B., Devauges V., Sara S.J. Limbic forebrain toxin trimethyltin reduces behavioral suppression by clonidine. Pharmacology, Biochemistry, and Behavior 1992, 42:313-316.
24. Segal M. Behavioral and physiological effects of trimethyltin in the rat hippocampus. Neurotoxicology 1988, 9:481-489.
25. Swartzwelder H.S., Dyer R.S., Holahan W., Myers R.D. Activity changes in rats following acute trimethyltin exposure. Neurotoxicology 1981, 2:589-593.
26. Swartzwelder H.S., Hepler J., Holahan W., King S.E., Leverenz H.A., Miller P.A., et al. Impaired maze performance in the rat caused by trimethyltin treatment: problem-solving deficits and perseveration. Neurobehavioral Toxicology and Teratology 1982, 4:169-176.
27. Woodruff M.L., Baisden R.H., Nonneman A.J. Anatomical and behavioral sequelae of fetal brain transplants in rats with trimethyltin-induced neurodegeneration. Neurotoxicology 1991, 12:427-444.
28. Walsh T.J., Miller D.B., Dyer R.S. Trimethyltin, a selective limbic system neurotoxicant, impairs radial-arm maze performance. Neurobehavioral Toxicology and Teratology 1982, 4:177-183.
29. Woodruff M.L., Baisden R.H., Cannon R.L., Kalbfleisch J., Freeman J.N. Effects of trimethyltin on acquisition and reversal of a light-dark discrimination by rats. Physiology & Behavior 1994, 55:1055-1061.
30. Earley B., Burke M., Leonard B.E., Gouret C.J., Junien J.L. A comparison of the psychopharmacological profiles of phencyclidine, ketamine and (+) SKF 10,047 in the trimethyltin rat model. Neuropharmacology 1990, 29:695-703.
31. Cho E.J., Hwang H.J., Kim S.W., Oh J.Y., Baek Y.M., Choi J.W., et al. Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob/ob mice. Applied Microbiology and Biotechnology 2007, 75:1257-1265.
32. Han B.Q. Experimental pharmacological study on polysaccharide of Tremella fuciformis spores. Zhong Yao Tong Bao (Beijing, China: 1981) 1982, 7:35-38.
33. Guo F.C., Kwakkel R.P., Williams B.A., Li W.K., Li H.S., Luo J.Y., et al. Effects of mushroom and herb polysaccharides, as alternatives for an antibiotic, on growth performance of broilers. British Poultry Science 2004, 45:684-694.
34. Guo F.C., Kwakkel R.P., Williams B.A., Parmentier H.K., Li W.K., Yang Z.Q., et al. Effects of mushroom and herb polysaccharides on cellular and humoral immune responses of Eimeria tenella-infected chickens. Poultry Science 2004, 83:1124-1132.
35. Gao Q., Berntzen G., Jiang R., Killie M.K., Seljelid R. Conjugates of Tremella polysaccharides with microbeads and their TNF-stimulating activity. Planta Medica 1998, 64:551-554.
36. Gao Q., Killie M.K., Chen H., Jiang R., Seljelid R. Characterization and cytokine-stimulating activities of acidic heteroglycans from Tremella fuciformis. Planta Medica 1997, 63:457-460.
37. Ukai S., Kiriki H., Nagai K., Kiho T. Synthesis and antitumor activities of conjugates of mitomycin C-polysaccharide from Tremella fuciformis. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 1992, 112:663-668.
38. Tsai C.H., Chang R.C., Chiou J.F., Liu T.Z. Improved superoxide-generating system suitable for the assessment of the superoxide-scavenging ability of aqueous extracts of food constituents using ultraweak chemiluminescence. Journal of Agricultural and Food Chemistry 2003, 51:58-62.
39. Ukai S., Kiho T., Hara C., Kuruma I., Tanaka Y. Polysaccharides in fungi. XIV. Anti-inflammatory effect of the polysaccharides from the fruit bodies of several fungi. Journal of Pharmacobio-dynamics 1983, 6:983-990.
40. Ukai S., Hirose K., Kiho T., Hara C., Irikura T. Antitumor activity on sarcoma 180 of the polysaccharides from Tremella fuciformis Berk. Chemical & Pharmaceutical Bulletin 1972, 20:2293-2294.
41. Wu Y., Shan L., Yang S., Ma A. Identification and antioxidant activity of melanin isolated from Hypoxylon archeri, a companion fungus of Tremella fuciformis. Journal of Basic Microbiology 2008, 48:217-221.
42. Gao Q., Seljelid R., Chen H., Jiang R. Characterisation of acidic heteroglycans from Tremella fuciformis Berk with cytokine stimulating activity. Carbohydrate Research 1996, 288:135-142.
43. Paxinos G., Watson C., Pennisi M., Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. Journal of Neuroscience Methods 1985, 13:139-143.
44. Fueger B.J., Czernin J., Hildebrandt I., Tran C., Halpern B.S., Stout D., et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2006, 47:999-1006.
45. Bao Q., Newport D., Chen M., Stout D.B., Chatziioannou A.F. Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2009, 50:401-408.
46. Kim J.S., Lee J.S., Park M.H., Kang H., Lee J.J., Lee H.J., et al. Assessment of cerebral glucose metabolism in cat deafness model: strategies for improving the voxel-based statistical analysis for animal PET studies. Molecular Imaging and Biology: MIB: the Official Publication of the Academy of Molecular Imaging 2008, 10:154-161.
47. Brown A.W., Aldridge W.N., Street B.W., Verschoyle R.D. The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat. The American Journal of Pathology 1979, 97:59-82.
48. Fortemps E., Amand G., Bomboir A., Lauwerys R., Laterre E.C. Trimethyltin poisoning. Report of two cases. International Archives of Occupational and Environmental Health 1978, 41:1-6.
49. Koczyk D., Skup M., Zaremba M., Oderfeld-Nowak B. Trimethyltin-induced plastic neuronal changes in rat hippocampus are accompanied by astrocytic trophic activity. Acta Neurobiologiae Experimentalis 1996, 56:237-241.
50. Zhao T.F., Xu C.X., Li Z.W., Xie F., Zhao Y.T., Wang S.Q., et al. Effect of Tremella fuciformis Berk on acute radiation sickness in dogs. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 1982, 4:20-23. (author's transl).
51. Andersson H., Luthman J., Lindqvist E., Olson L. Time-course of trimethyltin effects on the monoaminergic systems of the rat brain. Neurotoxicology 1995, 16:201-210.
52. Kim J.H., Ha H.C., Lee M.S., Kang J.I., Kim H.S., Lee S.Y., et al. Effect of Tremella fuciformis on the neurite outgrowth of PC12h cells and the improvement of memory in rats. Biological & Pharmaceutical Bulletin 2007, 30:708-714.
53. Lonze B.E., Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35:605-623.
54. Sala C., Rudolph-Correia S., Sheng M. Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 2000, 20:3529-3536.
55. Bourtchuladze R., Frenguelli B., Blendy J., Cioffi D., Schutz G., Silva A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79:59-68.
56. Mantamadiotis T., Lemberger T., Bleckmann S.C., Kern H., Kretz O., Martin Villalba A., et al. Disruption of CREB function in brain leads to neurodegeneration. Nature Genetics 2002, 31:47-54.
57. Jackson T., Ramaswami M. Prospects of memory-modifying drugs that target the CREB pathway. Current Opinion in Drug Discovery & Development 2003, 6:712-719.
58. Kogan J.H., Frankland P.W., Blendy J.A., Coblentz J., Marowitz Z., Schutz G., et al. Spaced training induces normal long-term memory in CREB mutant mice. Current Biology: CB 1997, 7:1-11.
59. Gao H.L., Xu H., Xin N., Zheng W., Chi Z.H., Wang Z.Y. Disruption of the CaMKII/CREB signaling is associated with zinc deficiency-induced learning and memory impairments. Neurotoxicity Research 2011, 19:584-591.
60. Tully T., Bourtchouladze R., Scott R., Tallman J. Targeting the CREB pathway for memory enhancers. Nature Reviews. Drug Discovery 2003, 2:267-277.
61. Mirrione M.M., Schiffer W.K., Siddiq M., Dewey S.L., Tsirka S.E. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse (New York, NY) 2006, 59:119-121.
62. Schiffer W.K., Mirrione M.M., Dewey S.L. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2007, 48:277-287.